Martin L Ogletree

Introduction

Martin L. Ogletree is a prolific inventor based in Newtown, PA, known for his significant contributions to the field of medical innovations. With a portfolio consisting of 8 patents, he has dedicated his career to developing advanced medical treatments that have the potential to improve patient outcomes.

Latest Patents

Among his latest inventions is a groundbreaking patent for a combination therapy involving an ADP-receptor blocking antiplatelet drug and a thromboxane A2 receptor antagonist. This method aims to inhibit thrombus formation by administering clopidogrel in combination with ifetroban and optionally a cholesterol-lowering drug like pravastatin. Additionally, he holds a patent for a method of treating dysmenorrhea using an interphenylene 7-oxabicycloheptyl substituted heterocyclic amide prostaglandin analog, specifically targeting menstrual cramps with innovative drug combinations.

Career Highlights

Throughout his career, Ogletree has made substantial contributions while working at esteemed companies such as E.R. Squibb & Sons, Inc. and Bristol-Myers Squibb Company. His experiences in these prominent organizations have fueled his passion for innovation in the pharmaceutical industry.

Collaborations

Martin has collaborated with notable colleagues, including Eugene H. O'Keefe and A.K. Aberg. Their partnerships have played a vital role in enhancing his research and development efforts, leading to significant advancements in medical therapies.

Conclusion

Martin L. Ogletree continues to exemplify the spirit of innovation in medicine through his outstanding inventive achievements. His work not only reflects his commitment to advancing healthcare but also his dedication to improving the quality of life for patients worldwide.